Indian CDMOs form trade group
Submitted by:
Andrew Warmington
At CPHI in Milan in October, eight Indian CDMOs announced that they have formed a
CPHI Frankfurt: Strong markets, multiple modalities
Submitted by:
Andrew Warmington
Pharmaceutical CDMOs are continuing to invest in a buoyant market. We report from CPHI Frankfurt
The agchem CDMO opportunity: Maximising India’s share
Submitted by:
Andrew Warmington
Amit Gandhi and Amita Parekh, managing directors and partners at BCG, look at
CPHI report: Get ready sooner
Submitted by:
Andrew Warmington
A new CPHI report highlights a significant shift in the pharma outsourcing market
A significant
CDMO relationships: Set your oversight early, but do not dictate all the rules
Submitted by:
Andrew Warmington
A little flexibility in approach will improve consistency and enable pharma partners to perform to
CDMO expansion for AGC
Submitted by:
Andrew Warmington
AGC is to expand the production lines of its AGC Wakasa Chemicals subsidiary at the
More CDMOs in COVID-19 deals
Submitted by:
Andrew Warmington
The ongoing race to develop the first effective vaccines for the treatment of COVID-19 continues
Feature article – Regaining independence in API production: A chance for European CDMOs
Submitted by:
Andrew Warmington
Roger-Marc Nicoud, CEO of Ypso-Facto, looks at the challenges and opportunities for CDMOs in the